| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |